Search

Your search keyword '"Shimizu, M."' showing total 804 results

Search Constraints

Start Over You searched for: Author "Shimizu, M." Remove constraint Author: "Shimizu, M." Publication Year Range Last 3 years Remove constraint Publication Year Range: Last 3 years
804 results on '"Shimizu, M."'

Search Results

3. Citizen Science Astronomy with a Network of Small Telescope: The Launch and Deployment of JWST

6. AB1414 THE LONG-TERM PROGNOSIS OF ANEURYSM FORMATION AND HYDRONEPHROSIS DUE TO IgG4-RELATED PERIAORTITIS/PERIARTERITIS AND RETROPERITONEAL FIBROSIS (IgG4-PA/RPF): A RETROSPECTIVE SINGLE-CENTER STUDY

7. POS0362 SUCCESSFUL DIFFERENTIATION OF IgG4-RELATED PERIAORTITIS/PERIARTERITIS AND RETROPERITONEAL FIBROSIS (IgG4-PA/RPF) FROM MIMICKERS BASED ON ILIAC ARTERY INVOLVEMENT, PRESENCE OF EXTRA-PA/RPF LESIONS, AND INCLUSION SCORES OF THE ACR/EULAR CLASSIFICATION CRITERIA FOR IgG4-RELATED DISEASE

8. An RNA Editing Approach for the Treatment of Alpha-1 Antitrypsin Deficiency (AATD)

12. Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial

13. A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function

14. Visual Outcome and Treatment Frequency of Anti-VEGF Therapy Using the Treat-and-Extend and Treatment Cessation Regimen for Exudative Age-Related Macular Degeneration and Pachychoroid Neovasculopathy

16. Charge states of nitrogen-vacancy centers in Fermi level controlled diamond n-i-n junctions.

17. Risk prediction of inappropriate implantable cardioverter-defibrillator therapy using machine learning

18. Comparison of historical criterion and artificial intelligence in patients with left ventricular hypertrophy

20. Clustering by artificial intelligence for multi-vessel coronary artery disease on electrocardiography gated single photon emission computed tomography

22. Impact of chronic kidney disease on the association of vascular endothelial growth factor D with cardiovascular mortality in patients with suspected or known coronary artery disease: the ANOX study

23. Diagnostic performance of machine learning on 12-lead electrocardiogram for predicting multi-vessel coronary vasospastic angina

26. P17-22: Phenotypic characterization of macrophages during peritoneal mesothelioma development induced by a multiwalled carbon nanotube in wild type C57BL mice

29. P796 Effectiveness and safety of ustekinumab for patients with ulcerative colitis: A single-centre retrospective study

35. Vascular endothelial factor C and D in patients with heart failure with preserved, mildly reduced, and reduced ejection fraction: the PREHOSP-CHF study

37. Serum amyloid A-low-density-lipoprotein complex and mortality in patients with suspected or known coronary artery disease: the ANOX study

38. Involvement of growth differentiation factor 15 in paradoxical relationship between body mass index and mortality in patients with suspected or known coronary artery disease; The ANOX Study

39. P.193 Phosphoryl guanidine-containing backbone modifications enhance exon skipping, dystrophin restoration and survival in a severe mouse model for DMD

40. Associations of soluble fms-like tyrosine kinase-1 with cardiovascular events and stroke in patients with atrial fibrillation and suspected or known coronary artery disease: the EXCEED-J study

41. Citizen science astronomy with a network of small telescopes: the launch and deployment of JWST

44. Recognition of pathogen-derived sphingolipids in Arabidopsis

45. Analysis of the circRNA and T-UCR populations identifies convergent pathways in mouse and human models of Rett syndrome

46. Search for proton decay via p -> μ+K0 in 0.37 megaton-years exposure of Super-Kamiokande

47. Prognostic value of machine learning for acute heart failure

48. Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial

Catalog

Books, media, physical & digital resources